Return to Stock, Expired Stock and Reverse Distribution

The idea in one paragraph

Every package in a pharmacy is in one of two places. It is either usable stock, which can be used to fill prescriptions, or it is isolated stock, which is kept apart until someone with the right authority decides where it goes. Your job as a technician is to put each item in the right place, send isolated items out only through an approved route, and write down what happened clearly enough that someone who wasn't there can follow it.

This lesson asks three questions about any stock problem:

1. Can this item be used? If not, isolate it.
2. Where does it go? Is it going back for credit, being destroyed, or both, and through which approved channel?
3. Could another person trace it? Is the record good enough for a pharmacist, inspector or supplier to follow the item from shelf to final destination?

What you will be able to do

• Decide whether a stock item is usable or must be isolated, by checking its dates, storage, recall status and supply-chain documents.
• Tell a credit return apart from disposal, and recognize the federal routes for controlled-substance inventory.
• Explain which decisions you can recognize and flag, and which belong to the pharmacist, manufacturer or another authority.
• Write a stock-problem record that lets someone else trace the item and the decision.

Before you start: You need everyday reading and arithmetic. It helps to have studied Controlled-substance schedules and valid orders and Read NDC segments and directory limitations. This lesson briefly explains the parts of those topics it uses.

Part 1: Usable stock versus isolated stock

The usability test

An item is usable only when all of these are true:

• Its identity is clear. You can read the drug name, strength, dosage form, NDC, lot number and expiration date.
• It is within date. Neither the expiration date nor any beyond-use date that applies to it has passed. When both apply, the earlier one controls.
• It was stored as its label requires.
• It is not in a recalled lot.
• It is not suspect. Nothing suggests it is counterfeit, stolen, tampered with or missing required supply-chain documents.
• It is not compromised. It is not contaminated, damaged or otherwise spoiled.

If even one item on this list fails, the package moves to isolated stock. Isolating stock means physically separating it from usable stock and labeling it so nobody fills a prescription from it by mistake. When the reason is that the product might be counterfeit or otherwise illegitimate, isolating is usually called quarantine.

Why separate it physically instead of just remembering? Because the danger is accidental use. CDC guidance on vaccines says expired doses should be removed immediately to avoid accidentally giving them. A bottle left on the regular shelf with a mental note is still within reach of the next busy person.

Recognizing a failed check is your job. Deciding what happens next often is not. For example, the pharmacist decides whether a borderline item can be used. For a vaccine with a storage problem, the manufacturer determines whether it is still viable. You do your part well by isolating first and asking second.

Reading an expiration date

An expiration date is the manufacturer's date for how long the product stays acceptable. Federal manufacturing rules require most drug products to carry one, with a few listed exceptions. The date is based on stability testing, which means testing how long the product keeps its identity, strength, quality and purity.

How you read the date depends on how it is written. CDC's vaccine guidance explains the rule:

• Month and year only (EXP 08/2027): usable through the last day of that month.
• Day, month and year (EXP 08/12/2027): usable through the end of that day only.

Worked example. Assume today is August 20, 2027.

• A bottle labeled EXP 08/2027 is still within date. It is good through August 31. Expiring "this month" does not mean expired.
• If the label instead read EXP 08/12/2027, the product expired eight days ago. It goes to isolated stock.
• If the label read EXP 07/2027, it expired at the end of July 31.

When a different date limits use

Some products get a beyond-use date (BUD). A BUD is a "use by" date that limits how long a product may be used after something happens to it. For example, many BUDs start once a product is opened, mixed or punctured. BUDs also come up in other settings, such as compounding or repackaging. A BUD can come before the printed expiration date.

A BUD can only shorten the usable period. It never extends it. When a product has both a BUD and a manufacturer's expiration date, the earlier date controls. A BUD never authorizes use after the manufacturer's expiration date. CDC's vaccine guidance says the BUD "replaces" the expiration date on the label. In practice, that means the BUD becomes the date you go by when it falls before the expiration date.

Here is an example based on CDC's vaccine guidance. A multidose vial's package insert says to throw the vial away 28 days after the first needle entry. The vial is first entered on May 3. Counting 28 days gives a BUD of May 31. On June 10, the vial is past its BUD, even if its printed expiration is December 2027. Now look at the reverse case. If the vial's printed expiration were May 15, the vial would be out of date after May 15, even though its 28 days hadn't run out.

In this example, the BUD rule comes from that product's own instructions. There is no single BUD rule for all products. Some products also need two dates. Federal rules require a product that is mixed (reconstituted) at dispensing to show expiration information for both the unmixed and the mixed form.

Why storage matters to the date

Federal rules tie the expiration date to the storage conditions stated on the label. The date assumes the product was kept as labeled. If a refrigerated product sat at room temperature, the testing behind its date no longer describes what happened to it.

For vaccines, CDC guidance says that if a temperature problem (a temperature excursion) is suspected, staff should:

• label the vaccine "DO NOT USE,"
• keep it in proper storage, separate from other vaccines, until a viability decision is made,
• notify the manufacturer, and
• contact the state or local immunization program for publicly funded vaccines.

Notice two things. First, the vaccine stays in proper storage rather than being thrown away, because it might still be usable. Second, you don't make the viability decision. For details on excursions, see Stability, storage and temperature excursions.

The tempting mistake is to think "the date hasn't passed and it looks fine, so it's usable." A product that is contaminated or compromised should not be used no matter what its date says. The date is one check, not the whole test.

Question 1

Today is March 14, 2028. You find three products on a shelf:

• Bottle A: EXP 03/2028, stored as labeled.
• Bottle B: EXP 03/09/2028, stored as labeled.
• Vial C: EXP 11/2028. Its package insert says to discard it 28 days after first entry. It was first entered on February 10, 2028.

Which items stay in usable stock?

Recalls: why the lot number matters

A recall is when a firm removes a product from the market or corrects it because of a problem. Federal recall guidance says a recall notice should identify the affected product clearly. That includes its size and lot numbers, codes or serial numbers. The notice should also say that further distribution or use should stop and explain what to do with the product. A pharmacy that receives the notice should carry out those instructions right away.

Two identifiers on a package answer two different questions:

• The NDC (National Drug Code) answers: which product is this? It identifies the labeler (the firm), the product (strength, dosage form and formulation), and the package size. It does not identify a particular manufacturing run.
• The lot number answers: which production run did this come from? Federally, a lot number is the code from which the complete history of a batch can be traced. That history covers manufacturing, packing, holding and distribution.

Recalls are often limited to specific lots. So you check the lot, not just the drug name or NDC.

Worked example. A recall notice lists one NDC, lot K4417 only. Your shelf has two bottles with that NDC.

• One is lot K4417. It goes to isolated stock, and you follow the notice's instructions.
• The other is lot K4502. That notice does not affect it. The bottle stays usable only if it passes the rest of the usability test.

Change one fact. Suppose your second bottle has the same drug name and strength but a different NDC from another labeler. This recall notice does not cover it. Having the same ingredient doesn't make two products the same, and it doesn't put them in the same recall. Go by the identifiers the notice lists.

For the full recall workflow, see Recalls, tracing and suspect products.

Suspect products and missing paperwork

The Drug Supply Chain Security Act (DSCSA) is a federal law that tracks prescription drugs as they move through the supply chain. Under DSCSA, FDA says pharmacies must:

• Only accept prescription drugs that come with product tracing documentation. These are the transaction records showing where the product came from. If the seller doesn't provide all of it, the pharmacy should work with the seller to get it promptly.
• Keep the tracing documentation it receives for six years.
• Have a process to quarantine and investigate suspect drugs. A suspect drug is one that may be counterfeit, diverted, stolen, intentionally adulterated or unfit for distribution.
• Notify after an illegitimate-product determination. If the investigation leads the pharmacy to determine that a drug is illegitimate, the pharmacy must notify FDA. It must also notify every immediate trading partner it has reason to believe may have received the product. Both notifications are due no later than 24 hours after the pharmacy makes that determination. The pharmacy must also take steps so patients don't receive the drug.

The 24-hour clock starts when the pharmacy determines the product is illegitimate. It does not start at the first suspicion. A suspect product is quarantined and investigated first. It is not "probably fine," and it stays in quarantine until the investigation decides.

Question 2

A delivery arrives. The tote holds a sealed bottle whose NDC, lot and expiration all look normal and within date. But the tracing documentation for that item is missing from the shipment and from the supplier's electronic record. A coworker says, "Everything on the label checks out, so shelve it." What should happen, and why?

Return to stock and patient returns

Return to stock (RTS) usually means taking a prescription that was filled but never picked up and putting the medicine back into inventory. There is no single national rule that allows or controls this. Pharmacy technician practice, including what technicians may do with returns, is defined by each state's Board of Pharmacy, and pharmacies also have their own policies. So "Can this be returned to stock?" is answered by your state's rules, your pharmacy's procedure and your pharmacist, not by a general rule you carry from job to job.

What carries over everywhere is the reasoning from this lesson. Any item going back to the shelf still has to pass the full usability test. Its identifying information, especially the lot number and expiration date, has to stay with it. If the lot number is lost, a later recall notice can't be matched to that container.

A medicine a patient brings back is a different situation. Federal rules are specific for controlled substances. A patient (an "ultimate user") may hand over their own Schedule II–V controlled substances for disposal only to:

• a DEA-registered collector, or
• law enforcement.

A collection receptacle is a secured drop box for patients' medicines. Federal rules say:

• Only patients and other authorized non-registrants may deposit items in it.
• The collector may not let the patient hand the substance to any person.
• Once something goes into the receptacle, it may not be counted, sorted, inventoried or handled individually.

So a patient's returned controlled substance never becomes pharmacy stock. If your pharmacy is a registered collector, the patient puts it in the receptacle. The reverse is also true: pharmacy inventory never goes into the receptacle, because the receptacle is only for patients' medicines.

Question 3

A patient brings a partly used bottle of their own Schedule IV tablets to the counter of a pharmacy that is a DEA-registered collector. They hold it out and ask the technician to "put it back on the shelf for someone who needs it." What should happen?

Part 2: Credit return versus disposal

Two different questions

Once an item is isolated, two separate questions come up:

• Credit answers: will the pharmacy get money or an account adjustment for this item? Credit comes from the supplier, the manufacturer or a returns program, under their own policies.
• Disposal answers: what physically happens to the product, and through whom? For example, is it destroyed on-site, picked up by an authorized company, or sent back to the supplier?

These questions are independent. CDC's vaccine guidance shows this clearly. Some unused, unopened or expired vaccine vials may be returned for credit even though they must be discarded. Other items cannot be returned at all, such as opened or broken vials, manufacturer-filled syringes that have been activated, and doses drawn up in advance. Those are discarded according to state requirements. The state or local immunization program or the manufacturer says which vaccines qualify.

The tempting mistake is to treat "we get credit for it" as a disposal route or as permission. Credit says nothing about whether the route is lawful, whether the product is usable, or whether waste rules apply. Answer the disposal question on its own terms.

Reverse distribution is the general name for moving products backward through the supply chain, from the pharmacy toward the manufacturer or a company that processes returns and destruction. A reverse distributor is a company that receives these products. For controlled substances, the reverse distributor must be registered with DEA.

Federal routes for controlled-substance inventory

A registrant is a person or business registered with DEA to handle controlled substances. A pharmacy is one. Federal rules give a pharmacy four ways to get rid of controlled substances in its own inventory:

1. Destroy them on-site promptly, following DEA's destruction rules.
2. Deliver them promptly to a DEA-registered reverse distributor. The reverse distributor picks them up at the pharmacy, or a common or contract carrier does.
3. For a return or recall, deliver them to the registrant the pharmacy got them from, the registered manufacturer, or another registrant the manufacturer has authorized to accept returns or recalls.
4. Ask the DEA Special Agent in Charge for the area for help. The pharmacy submits a DEA Form 41 listing the substances and then follows DEA's instructions.

DEA's Pharmacist's Manual adds a warning: never send drugs to DEA unless DEA has approved it in advance. The collection receptacle is not on this list, as Part 1 explained.

The paperwork follows the schedule

For transfers to a reverse distributor for destruction, the paperwork depends on the drug's schedule:

• Schedule II: the reverse distributor issues a DEA Form 222 (the official order form for Schedule I and II drugs) or its electronic equivalent to the pharmacy. Form 222 is the order document. The party receiving the drugs prepares it, the same way a buyer does.
• Schedules III–V: the pharmacy keeps its own record of distribution. That record includes the drug name, dosage form, strength, quantity and the date transferred. Federal record rules also require the recipient's name, address and DEA registration number. Treat this as the minimum, not a complete list.

DEA Form 41 is a separate document. The registrant that actually destroys a controlled substance keeps a record of destruction on Form 41, including the names and signatures of the two employees who witnessed it. When a reverse distributor does the destroying, the reverse distributor keeps the Form 41. Form 41 is not the record of the transfer between the pharmacy and the reverse distributor.

A return or recall is not the same as destruction, and it has its own rules. Each one needs a record. Returning a Schedule I or II drug for a return or recall also requires an order form handled the way DEA's order-form rules describe. Day-to-day controlled ordering and loss reporting are covered in Controlled inventory, ordering and losses.

Worked example: one change, different paperwork

The pharmacist decides to send 60 expired tablets of a Schedule III product to a DEA-registered reverse distributor for destruction. The pharmacy keeps a distribution record showing:

• drug name, dosage form and strength,
• quantity: 60 tablets,
• the date the reverse distributor actually picked them up, and
• the reverse distributor's name, address and DEA registration number.

Change only the schedule to Schedule II. The route stays the same. Now the reverse distributor must issue a Form 222 or its electronic equivalent to the pharmacy for the transfer. In both versions, the reverse distributor keeps the Form 41 when it destroys the drugs, not the pharmacy.

Waste rules apply on top of credit and schedule

The EPA (Environmental Protection Agency) prohibits healthcare facilities and reverse distributors from flushing or pouring hazardous waste pharmaceuticals down a drain. This is called the sewer ban. For this rule, "healthcare facilities" include retail, mail-order and long-term care pharmacies. The ban applies in all states.

Some examples of how a pharmaceutical can be hazardous waste:

• Cyclophosphamide, a chemotherapy drug, is on EPA's hazardous waste lists (code U058).
• A liquid can have the ignitable characteristic, which is one of the hazardous characteristics. Under EPA's definition, a liquid waste is ignitable if its flash point is below 60°C (140°F). Aqueous solutions containing less than 24 percent alcohol by volume are excluded. So an alcohol content of 24 percent or more only means that exclusion doesn't apply. Alcohol percentage alone does not make a liquid ignitable. The flash point and any other applicable exclusions still have to be evaluated.
• Controlled substances that are also hazardous waste are covered by the ban.

EPA says it is the pharmacy's or reverse distributor's legal responsibility to determine which of its pharmaceuticals are hazardous waste. As a technician, you follow that determination. You don't make it from the label.

The sewer ban itself covers hazardous waste pharmaceuticals. For other drugs, EPA strongly discourages sewering any pharmaceutical. That is a separate point from the ban, and state or local rules may go further. FDA's "Flush List" of drugs that may be flushed is meant for households only, not for pharmacies.

Federal rules don't replace state rules. DEA requires controlled-substance destruction to follow applicable federal, state, tribal and local laws. CDC notes that state environmental agencies set medical waste disposal requirements. When you see a federal rule, also ask what your state adds. For waste handling in more depth, see Hazardous handling, returns and disposal. For tracing returns through approved channels, see Trace pharmacy inventory through authorized return channels.

Question 4

A coworker suggests two shortcuts for a box of expired pharmacy inventory:

• (a) Put the expired Schedule II vials in the pharmacy's collection receptacle "since it all gets destroyed anyway."
• (b) Pour an expired oral solution down the sink, because "it isn't controlled." The solution contains 30 percent alcohol, and the pharmacy's hazardous waste determination has identified it as an ignitable hazardous waste pharmaceutical.

What is wrong with each?

Question 5

A vaccine manufacturer's program accepts unopened expired vials for credit. Does that mean the pharmacy can skip the state's disposal requirements for those vials? And can it return an opened vial for credit?

Part 3: Write a record someone else can trace

The trace test

A good record lets someone who wasn't there answer every one of these questions without asking you:

• What exactly is it? Drug name, strength, dosage form and NDC.
• Which units? Lot number, expiration date and exact quantity.
• Why was it pulled? For example, expired (with the date), a recall (with the notice and the matching lot), a temperature excursion, missing tracing documents, or damage.
• Where is it now? The isolation location and how it is labeled.
• Who did what, and when? Who found and isolated it, who was notified, and who made the decision.
• What was decided? Return for credit, recall return, or destruction, and through which approved channel.
• Where did it go? The recipient's name, address and, for controlled substances, DEA registration number. Also the forms used and the date it actually left the pharmacy.

Federal record rules say to use the date controlled substances were actually transferred or destroyed, not the date they were pulled or the date the paperwork was started.

Counting has to be exact, but a correct count only gives you the quantity. It doesn't make the product usable or the route lawful.

Worked example: weak versus traceable

Weak record:

"Pulled some expired stuff, sending out."

Another person can't tell which product, which lot, how much, where it is or where it went. If a recall notice arrived next week, nobody could tell whether these units were part of it.

Traceable record:

9/14/2027 — [Drug name], 10 mg tablets, NDC [full NDC], lot R2210, EXP 08/2027. Qty 84 tablets in 1 opened bottle. Reason: expired, found during monthly date check. Isolated in labeled "DO NOT DISPENSE" bin, back shelf 3, by [technician initials]. Pharmacist [initials] notified 9/14 and approved return through [reverse distributor name, address]. Picked up 9/20/2027.

Change one fact

Suppose these same tablets were pulled because of a recall instead of expiration. The record would then also name the recall notice and confirm that lot R2210 matches the lot it lists. It would also record which of the notice's instructions were followed. The reason line changes because the reason determines what the recipient and the recalling firm need to know.

Question 6

A record reads:

"Schedule IV tablets, 1 bottle, sent to reverse distributor for destruction."

Using only this lesson, list what is missing.

Independent practice

Each case gives all the facts you need. Decide first, then check the explanation.

Question 7

Today is October 3, 2027. A filled prescription was never picked up. The label shows the product, its NDC, lot and EXP 10/2027. Your state and pharmacy policy permit returning unclaimed prescriptions to stock under a pharmacist's review. Is the date by itself a reason to isolate this item instead of returning it?

Question 8

A recall notice lists lot M330 of a particular NDC. Your shelf has lot M330 of a product with the same drug name and strength but a different NDC. Is your bottle covered by this notice?

Question 9

A pharmacy wants to get rid of expired Schedule II inventory. A staff member suggests shipping it to the local DEA office because "DEA handles controlled drugs." What does federal guidance say, and what are the approved routes?

Question 10

A vaccine shipment arrives, and the cold chain monitor suggests a temperature excursion happened during transit. A technician wants to throw the vaccines away to be safe. Another wants to put them in the regular stock refrigerator because they "look normal." What does CDC guidance support?

Question 11

Write a traceable record for this case: On February 2, 2028, you find 2 unopened vials of a non-controlled injectable labeled EXP 01/2028, lot T81. They are isolated in the labeled return bin. The pharmacist approves sending them to the pharmacy's returns processor, which offers credit. They leave with the processor's pickup on February 9, 2028. Which date belongs in the "date sent" field, and does the credit offer settle how the vials will be disposed of?

What to remember

• Usable means every check passes. The product's identity is clear, it is within its expiration date and any applicable BUD (read correctly), it was stored as labeled, it isn't in a recalled lot, it isn't suspect, and it isn't compromised. Any failure means isolate it, label it, and tell the pharmacist.
• The earlier applicable date controls. A BUD can shorten the usable period but never authorizes use past the manufacturer's expiration date.
• The NDC identifies the product. The lot identifies the production run. Recalls are matched by the identifiers the notice lists.
• Suspect products are quarantined and investigated. Once the pharmacy determines a product is illegitimate, it must notify FDA and the immediate trading partners it has reason to believe may have received it, no later than 24 hours after that determination.
• Return to stock is set by state law and pharmacy policy. A patient's returned controlled substance goes to an authorized collector's receptacle or to law enforcement, never to stock. Pharmacy inventory never goes in the receptacle.
• Credit and disposal answer different questions. Credit is about money. Disposal is about what physically happens and through whom.
• Controlled-substance inventory leaves only through federal routes. For destruction transfers, Schedule II needs a Form 222 or its electronic equivalent issued by the reverse distributor. Schedules III–V need the pharmacy's own distribution record. Whoever destroys the drugs keeps the Form 41.
• Pharmacies may not flush hazardous waste pharmaceuticals. Whether a drug is hazardous waste is the facility's determination. Alcohol percentage alone doesn't establish ignitability. EPA strongly discourages sewering other drugs too. The Flush List is for households only. State rules apply on top of federal rules.
• A traceable record answers what, which units, how many, why, where, who, what was decided, where it went and when, using the actual transfer date.

Continue to Mixed review and your next study cycle when you're ready to mix these decisions with other topics.

Review: Start with status, not shelf space

• Part 1: Usable stock versus isolated stock

Review: Trace the outgoing product

• Part 2: Credit return versus disposal
• Part 3: Write a record someone else can trace